Latest News

New Insight Into ‘Demon’ Facial Visual Perception Disorder


 

Eye-Opening Findings

The patient described the visual facial distortions as “severely stretched features, with deep grooves on the forehead, cheeks, and chin.” Even though these faces were distorted, he was able to recognize the people he saw.

Because the patient reported no distortion when viewing facial images on a screen, researchers asked him to compare what he saw when he looked at the face of a person in the room to a photograph of the same person on a computer screen.

The patient alternated between observing the in-person face, which he perceived as distorted, and the photo on the screen, which he perceived as normal.

Researchers used real-time feedback from the patient and photo-editing software to manipulate the photo on the screen until the photo and the patient’s visual perception of the person in the room matched.

“This is the first time we have actually been able to have a visualization where we are really confident that that’s what someone with PMO is experiencing,” said Dr. Duchaine. “If he were a typical PMO case, he would look at the face in real life and look at the face on the screen and the face on the screen would be distorting as well.”

The researchers discovered that the patient’s distortions are influenced by color; if he looks at faces through a red filter, the distortions are greatly intensified, but if he looks at them through a green filter, the distortions are greatly reduced. He now wears green-filtered glasses in certain situations.

Dr. Duchaine hopes this case will open the eyes of clinicians. “These sorts of visual distortions that your patient is telling you about are probably real, and they’re not a sign of broader mental illness; it’s a problem limited to the visual system,” he said.

The research was funded by the Hitchcock Foundation. The authors reported no relevant conflicts of interest.

A version of this article appeared on Medscape.com.

Pages

Recommended Reading

Breastfeeding by patients with serious mental illness: An ethical approach
MDedge Psychiatry
Toward a better framework for postmarketing reproductive safety surveillance of medications
MDedge Psychiatry
ADHD Plus Comorbidities Linked to Increased Schizophrenia Risk
MDedge Psychiatry
Cannabis for Psychiatric Disorders? ‘Not Today,’ Experts Say
MDedge Psychiatry
Higher-Dose Atypical Antipsychotics Risky in Young Adults
MDedge Psychiatry
Spike in Schizophrenia-Related ED Visits During COVID
MDedge Psychiatry
Positive Phase 3 Results for Novel Antipsychotic in Schizophrenia
MDedge Psychiatry
Schizophrenia Med Safe, Effective for Bipolar Mania: Phase 3 Data
MDedge Psychiatry
Number of State Psychiatric Hospital Beds Hits Historic Low
MDedge Psychiatry
Long-Acting Injectable Antipsychotics Reduce Schizophrenia Readmission
MDedge Psychiatry